Patent Assignment
Reel/Frame 029636/0944
Change of Name
Recorded: 2013-01-16
Pages: 13
Assignor
JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Executed: 2010-04-01
Assignee
THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
1-6-1 OKUBO, KITA-KU, KUMAMOTO-SHI, KUMAMOTO, 860-8568, JAPAN
Covered Properties
(47)
Exogenous Gene Expression Vector Containing Chick Beta-Actin Gene Promoter
Patent:
5,811,260 →
Application:
07/373,143 →
Anti-Feline Calicivirus Recombinant Antibody and Gene Fragment Encoding the Same
Patent:
5,785,968 →
Application:
08/024,253 →
Cat-Mouse Heterohybridoma and Gene Fragment Coding for Constant Region of Feline Immunoglobulin
Patent:
5,504,198 →
Application:
08/247,486 →
Recombinant Marek's Disease Virus, Process for Preparing the Same and Vaccine Containing the Same
Patent:
5,558,867 →
Application:
08/272,513 →
Process for Preparing Human Coagulation Factor Viii Protein Complex
Patent:
5,693,499 →
Application:
08/276,594 →
Anti-Hiv Monoclonal Antibody
Patent:
6,114,143 →
Application:
08/513,968 →
Method of Stabilizing Protein C or Activated Protein C and the Stabilized Composition Obtained by Said Method
Patent:
5,962,299 →
Application:
08/633,834 →
Human Activated Protein C and Process for Preparing Same
Patent:
5,831,025 →
Application:
08/637,662 →
Recombinant Marek's Disease Virus (Mdv) and Vaccine
Patent:
6,013,261 →
Application:
08/776,660 →
Method for Activating Prothrombin with Polyethylene Gylcol
Patent:
5,811,279 →
Application:
08/905,041 →
Novel Polypeptide Originating in Hemophilus Paragallinarum and Process for Producing the Same
Patent:
6,544,519 →
Application:
09/077,098 →
Immunoregulatory Molecules for Costimulatory Signal Transduction
Patent:
6,429,286 →
Application:
09/403,089 →
In Ovo Vaccination of 1 Type Marek's Disease Virus
Patent:
6,410,222 →
Application:
09/622,093 →
Clonal Expansion of T Cells of Unknown Specificity and Identification of Ligand Recognized by the Clonally Expanded T Cells
Medicinal Compositions for Treating and Preventing Diseases Based on Abnormal Blood Coagulation
Medicinal Compositions for Preventing and Treating Hemorrhagic Diseases Associating Thrombopathy
Cell Usable in Serum-Free Culture and Suspension Culture and Process for Producing Virus for Vaccine by Using the Cell
Human-Type Anti-Blood Coagulation Factor Viii Antibody
Process for Producing Human Thrombin by Gene Modification Technique
Pharmaceutically Stable Hemostatic Compositions
Human Type Antihuman Ige Receptor Antibody and Fragment
Human Antihuman Interleukin-6 Antibody and Fragment of Antibody
Human Antihuman Mcp-1 Antibody and Antibody Fragment Thereof
Hemostatic materials
Application:
10/542,577 →
Publication:
US 2006/0051340
Method for Enhancing Efficacy of Preparation of Monoclonal Antibody
Process for Producing Albumin Preparation
Method for Purifying Modified Major Mite Allergen
Process for Preparing Variant of Erysipelothrix Rhusiopathiae Surface Protective Antigen in E. Coli
Human Anti-Amyloid Beta Peptide Antibody and Fragment of Said Antibody
Method for Improving Antibody
Bioabsorbable Synthetic Nonwoven Fabric Holding Thrombin
Modified Transposon Vector and Its Use
Method for Quantification of Neurotoxin
Method for Propagating Influenza Virus
Process for Preparing Live Smallpox Vaccine
Highly Purified Type A Botulinum Toxin Preparation From Infant Botulism Pathogen
Solid Fibrinogen Preparation
Method for Enhancing Immune Response with Peptide
Spray Head, and Apparatus and Method for Applying Biological Tissue Adhesive
Application:
12/664,823 →
Publication:
US 2010/0198255
Novel Adamts-13 Mutant
Method for Quantification of Titer of Neutralizing Antibody to Neurotoxin
Application:
12/673,980 →
Publication:
US 2011/0105940
Recombinant Factor X with No Glycosylation and Method for Preparing the Same
Human Anti-Amyloid Beta Peptide Antibody and Fragment of Said Antibody
Process for Preparing Variant of Erysipelothrix Rhusiopathiae Surface Protective Antigen in E. Coli
Method for Enhancing Immune Response with Peptide
Recombinant Factor X with No Glycosylation and Method for Preparing the Same
Recombinant Factor X with No Glycosylation and Method for Preparing the Same
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 7, 2001
From: MATSUSHITA, SHO; NAKASHIMA, TOSHIHIRO
To: JURIDICAL FOUNDATION THE CHEMOSERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 012298/0852 →
Assignment of Assignor's Interest
Apr 15, 2004
From: AKAKI, TATSUYA; TOMOKIYO, KAZUHIKO; NAKATOMI, YASUSHI; TESHIMA, KAORI
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 015219/0400 →
Assignment of Assignor's Interest
Jul 20, 2004
From: YONEMURA, HIROSHI; IMAMURA, TAKAYUKI; NAKATAKE, HIROSHI; SOEJIMA, KENJI
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 015587/0988 →
Assignment of Assignor's Interest
Jul 6, 2005
From: SUGIMURA, KAZUHISA; NAKASHIMA, TOSHIHIRO; TORIKAI, MASAHARU
To: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 016227/0982 →
Change of Address of Assignee
Apr 15, 2019
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 050169/0778 →
Assignment of Assignor's Interest
Jan 15, 2020
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: KM BIOLOGICS CO., LTD.
Reel/Frame 051520/0971 →